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CIRCADIAN RHYTHMS HAVE EVOLVED AS A BIOLOG-
ICAL ADAPTATION TO THE LIGHT-DARK CYCLE AND 
OTHER ENVIRONMENTAL DAILY CYCLES, WHICH 
currently have a period of 24 hours.1,2 These rhythms enable 
organisms to anticipate and to entrain to the changing physi-
cal conditions associated with the daily transition between day 
and night. Similarly, sleep has evolved in animals as a neces-
sary period of restoration for the brain and the body. While 
they remain independent mechanisms, the circadian and sleep 
homeostatic systems show high levels of interaction.3 Inter-
individual differences prevail in both systems.4-7 Differences in 
chronotype and sleep-wake timing can be studied by a simple, 
questionnaire-based assessment of diurnal preference.8 Labo-
ratory-based studies have confirmed that morning or evening 
preference correlates with differences in the phase and period 
of circadian markers, such as core body temperature and mela-
tonin rhythms.9,10 It has also been shown that diurnal preference 
is associated with differences in sleep structure,11,12 and survey 
data have highlighted large inter-individual differences in sleep 
duration and sleep timing.13
Almost all cells in the mammalian body possess the ability 
to generate circadian rhythms, which are synchronized by the 
central pacemaker in the SCN through mechanisms that have 
only in part been elucidated. These can include humoral and 
behavioral mechanisms, such as feeding and sleep-wake ac-
tivity.14 The core molecular components of the clock are well 
established, although additional elements continue to be dis-
covered, especially in output pathways where the cellular clock 
links to biochemical processes under circadian influence. The 
core mechanism is thought to consist of positive transcription 
factors promoting the expression of a set of proteins which feed 
back negatively to inhibit the transcription of their own mRNA. 
The whole cycle has a period of approximately 24 h. The ex-
act period length is fine-tuned by posttranslational mechanisms 
such as phosphorylation, which (depending on the target site) 
can act to shorten or lengthen the period.15 Less is known about 
the molecular components of the sleep homeostat, although 
several genes have been linked with sleep regulation, includ-
ing alleles of the human leukocyte antigen (HLA) complex, 
the prion protein gene (PRNP), the pre-prohypocretin gene, the 
gamma amino butyric acid A (GABAA) beta3 gene, the myo-
tonic dystrophy type 1 (DM1) protein kinase gene, catecholo-
methyltransferase (COMT), tumor necrosis factor alpha (TNF), 
adenosine deaminase (ADA), and the adenosine A2A receptor 
(ADORA2A), among others.16-18 Animal studies have indi-
cated an interaction between the circadian clock and the sleep 
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homeostat through the discovery of altered sleep structure in 
clock gene knockout mice.19-21 It has also been established that 
polymorphisms within human clock genes can affect diurnal 
preference,22-24 sleep timing,25,26 and sleep structure.27 The vari-
able number tandem repeat (VNTR) polymorphism in PER3, 
where a 54-nucleotide coding region motif is repeated in 4 or 
5 units, has been linked with multiple phenotypic parameters. 
The longer, 5-repeat allele has been associated with morning 
preference,23,28 and higher sleep propensity and worse cognitive 
performance in response to sleep deprivation,27 as well as being 
linked with an increased risk of breast cancer.29
Traditionally, the circadian marker of choice in humans has 
been the hormone melatonin, because its rhythm is driven by 
the SCN through a well-defined neural pathway, and because it 
can be monitored conveniently and reliably in a variety of body 
fluids.30 Assessment of endogenous circadian phase and period 
of melatonin correlates well with phenotypes of interest, such 
as sleep timing and diurnal preference.10 More recently, meth-
ods have been developed to specifically access molecular clock 
components in the periphery (for review, see Lamont et al.).31 
Analysis of clock gene expression in cultured fibroblasts could, 
in theory, provide useful information about individual circadian 
period without the need for elaborate forced desynchrony proto-
cols, but results of these approaches have been mixed so far.32 It 
has also been established that peripheral, nucleated blood cells 
show rhythmic clock gene expression in vivo, and several stud-
ies have sought to refine the technique for quantifying clock 
gene transcripts in a variety of leukocyte preparations, collected 
from subjects kept under varying conditions.33-40 While these 
studies have demonstrated the utility of this approach, few 
have shown a correlation between endogenous peripheral oscil-
lations in clock gene expression and habitual sleep timing or 
hormonal markers such as melatonin or cortisol. In particular, 
it is not known whether variation in the phase of endogenous 
circadian rhythms of clock gene expression in the periphery, 
correlates with the entrained phase of the habitual sleep-wake 
cycle, even in the absence of the masking effects of the light-
dark and sleep-wake cycle.41 In this study, we have assessed 
this relationship for the clock genes BMAL1 (ARNTL), PER2, 
and PER3 under constant routine conditions. We show for the 
first time that the phase of peripheral clock gene expression in 
leukocytes correlates with habitual sleep timing and that PER3 
expression represents the most robust of the 3 markers of circa-
dian gene expression.
MEtHodS
participants
The protocol received a favorable review by the University 
of Surrey Ethics Committee, and was conducted in accordance 
with the principles of the Declaration of Helsinki. Participants 
in the study were screened for health (by history, physical ex-
amination, and standard biochemistry and hematology), and 
did not suffer from sleep disorders or excessive daytime sleepi-
ness. All participants provided written, informed consent after 
having received a detailed explanation of the study procedures. 
Participants were also selected according to their genotype for 
the PER3 VNTR polymorphism as part of a larger study from 
which the data presented here have been derived (described 
previously in Viola et al.).27 10 participants were homozygous 
for the longer repeat allele (PER35/5) and 14 were homozygous 
for the shorter repeat allele (PER34/4) (see Table 1 for subject 
characteristics).
Field Study
The selected participants took part in a pre-laboratory field 
study to determine individual sleep-wake schedules. Subjects 
wore actigraphs (wrist-worn Actiwatch L, Cambridge Neuro-
technology, Cambridge, UK) to quantify activity,42 and com-
pleted daily sleep diaries for approximately 3 weeks (on average 
2.70 ± 0.17) prior to the laboratory study. The data of the first 
2 weeks were analyzed to characterize the habitual sleep-wake 
cycle in each participant. Individual habitual sleep onset and 
wake times were determined from values calculated during this 
2-week period based on the sleep diary data and corroborated 
by actiwatch data, which both showed very close agreement. 
Sleep onset was defined as the “lights-out” time plus the indi-
vidual sleep latency time, which was estimated by the subject 
and recorded in the sleep diary. This time was also confirmed by 
inactivity in the actiwatch data. Habitual timing was defined as 
the median of these values. Participants were then instructed to 
sleep according to their habitual schedule for one week prior to 
the laboratory study. Compliance with this schedule was veri-
fied by analysis of the sleep diary and actigraphy prior to the 
start of the 5-day laboratory study. Neither meal times nor con-
tent were controlled during the field study.
laboratory Study
On entering the laboratory phase, participants underwent 
habituation and baseline sleep episodes, which were timed ac-
cording to each individual’s habitual sleep schedule determined 
from the field study. Immediately following this, participants 
were kept awake under an approximate 40-h constant routine 
(CR) condition, as previously described.27 During the CR pro-
tocol, participants stayed in bed in a semi-recumbent position in 
constant environmental conditions with no information on clock 
time. Participants received hourly nutritional drinks during the 
CR as a substitute for main meals. These were calculated for 
each subject using the Harris-Benedict formula with an activity 
factor of 1.3.43 The participants were not allowed to leave the 
bed for the duration of the protocol. Wakefulness was verified 
from continuous electroencephalogram (EEG) and electroocu-
logram (EOG) recordings. During the CR period, hourly blood 
samples were collected from a permanent indwelling cannula 
to quantify melatonin, cortisol and clock gene mRNA. After the 
CR, volunteers went to bed in the laboratory at their habitual 
bedtime for a recovery sleep episode of 12 h, during which time 
they were free to sleep or get up as desired.
Hormone and clock Gene Measurements
For the measurement of melatonin and cortisol, hourly blood 
samples (7 mL) were collected into lithium-heparin tubes. Plas-
ma was immediately separated by centrifugation (10 min, 1,650 
x g, 4°C) and stored at -20°C until analysis. Plasma melatonin 
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and cortisol concentrations were measured by radioimmuno-
assay (Stockgrand Ltd, Guildford, Surrey, UK), as previously 
described.27
Analysis of clock gene expression followed modifications of 
previously published methods.37,39 Hourly blood samples (2.5 
mL) were collected into PAXgene Blood RNA vacutainer tubes 
(PreAnalytiX, Hombrechtikon, Switzerland), mixed by inver-
sion, incubated at room temperature for several hours, and then 
frozen at -20°C until extracted using the PAXgene 96 Blood 
RNA Kit (QIAGEN, Hilden, Germany). Extracted total RNA 
was analysed spectrophotometrically (ND-1000, NanoDrop 
Technologies, Wilmington, DE). Then 100 ng of each sample 
was subjected to random-primed reverse transcription by M-
MLV reverse transcriptase (Invitrogen, Carlsbad, CA) in a to-
tal volume of 40 µL; 6.25% of the resulting cDNA was used 
in each real-time PCR reaction and amplified by the ABsolute 
QPCR ROX mix (ABgene, Epsom, Surrey, UK) in a 96-well 
plate format in an ABI Prism 7500 instrument (Applied Biosys-
tems, Foster City, CA). Primer and probe sequences are shown 
in Table 2. All probes were labelled with FAM at the 5’-end and 
Black Hole Quencher 1 at the 3’-end. Standard curve controls 
were dilutions of human genomic DNA (for GAPDH) and a 
sequence-verified cDNA clone (for PER2, PER3, and BMAL1), 
respectively. The clock gene primers and probes were designed 
to amplify only cDNA. Negative controls included reverse-
transcription reactions where RNA had been omitted, as well as 
blanks to which no cDNA had been added. Amplification curves 
were analyzed using the Prism 7500 software with log CT val-
ues being normalized against the standard curves to produce 
relative copy number. Clock gene expression data were normal-
ized against levels of the housekeeping transcript GAPDH.
data analysis
The analysis of the circadian markers aimed to assess the 
presence of circadian rhythmicity, and to quantify the amplitude 
and the phase of these rhythms. For the purpose of the present 
paper, an individual time series was considered to be rhythmic 
if the 95% confidence interval of the estimated amplitude of 
a sine wave with a circadian period of 24.2 h did not include 
0. Using a nonlinear regression procedure (PROC NLIN, SAS 
9.1), the function fitted to the data was:
Value(sample ti) = Mesor + Amplitude*sin((sample ti-
phase)/24.2), in which the mesor, amplitude and phase were 
free parameters, ti represents the clock time i at which a sample 
was collected, and value represents the concentration or copy 
number of the circadian marker variable. These analyses were 
conducted on the raw data (clock gene relative copy number, 
nmol/L of cortisol, and pg/mL of melatonin), clock gene rela-
tive copy number normalized with respect to GAPDH, and z-
scored data, which for the hormones was the z-scored raw data, 
and for the clock genes was the z-scored normalized data. Here, 
analyses conducted on the z-scored data are presented through-
out, unless specifically stated. The analysis of the z-scored data 
was used to allow for a comparison of amplitudes across vari-
ables that are measured in different units. This approach first 
equates the total variance in each variable in each individual, 
and then determines how much of this variance can be attrib-
uted to a circadian signal.
The start of the recovery sleep episode after the CR was timed 
to occur 48 h after the habitual sleep onset time for each indi-
vidual. Thus, because of differences in habitual sleep and wake 
timing between subjects, the individual CRs varied in duration 
from 37.8 to 42.5 h. Because of the individual habitual schedul-
ing, not all individuals contributed data during the beginning 
and the end of the 42.5 h CR session. Data were included for 
analysis from a window within the CR when at least 80% of 
the individuals contributed data. The longest period within the 
CR session when hourly clock gene data were available from 
at least 80% of the participants was 32 h, and data analysis 
has been restricted to this period. Within this period, the mean 
number of subjects contributing data at each sampling hour was 
95%. The exclusion of the initial and final hours of the CR data 
also helps to avoid potential masking effects on physiological 
variables of sleep and change in posture that may last for sev-
eral hours after wake time.41
The phase of the melatonin rhythm was defined either on the 
basis of the onset of the nocturnal secretion, i.e. the time when 
melatonin concentration first exceeds the mean value, or the 
timing of the fitted maximum. The phase of the cortisol rhythm 
was defined as the fitted maximum. For both melatonin and 
cortisol, simple sinusoid functions were fitted to the individual 
Table 1—Subject Characteristics
PER3 Polymorphism PER35/5 PER34/4 P
N 10 14 
Age 25.2 ± 1.1 24.8 ± 1.0 0.8
BMI 22.6 ± 0.6 21.5 ± 0.4 0.2
Sex (M/F) 6/4 8/6 0.9
Women in luteal phase 1 1 
Ethnicity 
  (European/Asian/African) 8/2/0 9/3/2 
Habitual bed time 01:03 ± 1:43 01:03 ± 1:17 0.9
Habitual wake time 07:57 ± 1:29 08:41 ± 01:19 0.2
Sleep duration 06:55 ± 1:01 07:38 ± 0:56 0.1
Subject characteristics split by PER3 VNTR genotype. Body-
mass index (BMI). Mean ± standard deviation. P values refer to 
comparisons between genotypes.
Table 2—Primer and Probe Sequences (5’ – 3’) for Q-PCR Templates
Gene Forward Primer Reverse Primer Probe
PER2 CTGCCTTCTGCTGGCAGAGA CCGCCCTTTCATCCACATC TGGTTATGAAGCCCCTAGAATTCCT
PER3 GGTCGGGCATAAGCCAATG GTGTTTAAATTCTTCCGAGGTCAAA CCCAGAGACAGCCAGGGATGCTACC
BMAL1 AAACCAACTTTTCTATCAGACGATGAA TCGGTCACATCCTACGACAAAC ACCTCATTCTCAGGGCAGCAGATGG
GAPDH CAAGGTCATCCATGACAACTTTG GGGCCATCCACAGTCTTCTG ACCACAGTCCATGCCATCACTGCCA
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least variance in amplitude and phase timing. Out of the 3 clock 
genes that were analyzed, PER3 had the more robust rhythm 
(individual data for relative copy number normalized with re-
spect to GAPDH for each clock gene are shown in Supplemen-
tary Figure 1). To further quantify the extent of circadian rhyth-
micity, we determined for each circadian marker the number 
of individuals in whom a significant circadian amplitude was 
detected.
The amplitude of rhythms differed significantly from zero in 
all 24 individuals for melatonin (14 PER34/4, 10 PER35/5), 23 for 
cortisol (13 PER34/4, 10 PER35/5), 19 for PER3 (11 PER34/4, 8 
PER35/5), 8 for BMAL1 (4 PER34/4, 4 PER35/5), and 8 out of 24 
individuals for PER2 (4 PER34/4, 4 PER35/5) (Figure 3A). The 
mean z-scored amplitudes (± SD) when all 24 individuals were 
analyzed were 0.48 ± 0.22 for PER2, 0.50 ± 0.27 for BMAL1, 
0.75 ± 0.27 for PER3, 1.04 ± 0.24 for cortisol, and 1.24 ± 0.09 
for melatonin (Figure 3B). The mean fitted z-scored amplitude 
of the PER3 rhythm was significantly greater than the PER2 
time series. The phase of the clock gene rhythms was defined as 
the timing of the fitted maximum.
Statistical analysis
All statistical analyses were performed using SAS version 
9.1 (SAS Institute, Cary, NC). PROC MIXED was used to 
compare amplitudes between variables. P values were based 
on Kenward-Roger’s corrected degrees of freedom.44 Compari-
sons of the variances (SD) of the peak timing of the clock gene 
rhythms were calculated using the F test. Correlations were 
computed with PROC CORR. Two dependent correlations 
measured on the same subjects (e.g. the correlation between ha-
bitual sleep timing and the rhythm of melatonin vs. the correla-
tion between habitual sleep timing and the rhythm of BMAL1), 
were compared using the Fisher Z transformation, after correct-
ing for the covariance between these correlations because one 
variable contributes to both correlations. Correlations obtained 
in 2 different groups of subjects (PER34/4 vs. PER35/5) were also 
compared, and for this we used the Fisher-Z transformation 
without correction.
RESultS
Analyses of the actigraphy and sleep diary data showed that 
individuals varied widely in their habitual sleep timing (Figure 
1). Habitual sleep timing ranged from 22:45 to 04:40 (onset), 
and 06:00 to 10:40 (offset). The mean (± SD) sleep onsets, 
mid sleep, wake times, and sleep duration were 01:03 ± 01:27, 
04:43 ± 01:20, 08:23 ± 01:25 and 07:20 ± 01:44 when the en-
tire sample was considered. There was no significant difference 
between these parameters when they were analyzed according 
to PER3 VNTR genotype (Table 1).
To investigate the inter-individual variation in the amplitude 
and phase of the five circadian markers, we plotted the curves 
fitted to z-scored data for each individual (Figure 2, left panel). 
The average profiles of the z-score values were also computed 
(Figure 2, right panel). As shown in Figure 2, melatonin had the 
Figure 1—Habitual sleep timing. Mean sleep onset, mean sleep 
mid-point (± SD), and mean wake times are shown for each indi-
vidual (gray bars), ordered by sleep mid-point. ● = PER34/4 sub-
jects, ▲ = PER35/5 subjects.
Figure 2—Individual and average oscillations in circadian mark-
ers. Left Panel: z-score normalized rhythms from individual sub-
jects for PER2, BMAL1, PER3, melatonin and cortisol plotted 
relative to clock time (data for clock genes are the relative copy 
number/GAPDH ratio). Right Panel: Average z-score curves for 
each marker for all individuals (± SD). Mean sleep onset and wake 
times are depicted as a bar above the melatonin profile (± SD).
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To investigate whether the correlations described above were 
affected by the PER3 polymorphism, the z-scored data for the 
phase timings of the circadian markers were split by genotype. 
(P = 0.0004) and BMAL1 (P = 0.0027) rhythms. This was also the 
case when the non z-scored data for the copy number/GAPDH 
ratio and the relative mRNA copy number were compared (Table 
3). When only significant amplitudes were included in the same 
analysis, the mean z-scored amplitudes were 0.72 ± 0.13 for 
PER2, 0.82 ± 0.16 for BMAL1, 0.85 ± 0.17 for PER3, and 1.08 
± 0.16 for cortisol (melatonin remained unchanged). With this 
analysis, the mean amplitude of PER3 was significantly greater 
than PER2 (P = 0.0004) and BMAL1 (P = 0.003).
The timing of the mean fitted z-scored maxima (peak times), 
as well as the inter-individual variation, differed between the 
various markers. Mean peak times (± SD) were computed from 
only those individuals contributing significant amplitudes. They 
were 8:06 ± 5:23 for PER2, 15:06 ± 4:28 for BMAL1, 6:05 ± 
2:14 for PER3, 10:49 ± 1:37 for cortisol, and 4:20 ± 1:18 for me-
latonin. Thus, the timing of the PER3 rhythm showed the least 
variance of the 3 clock genes (Figure 3C) and was significantly 
lower than the variance of PER2 (P = 0.003) and BMAL1 (P = 
0.017). There was no significant difference between the peak 
times of PER3 and PER2 (P = 0.33), but the peak times of PER3 
and PER2 were significantly different from that of BMAL1 (P = 
0.0005 and P = 0.014, respectively). When z-scored data from 
all individuals were analyzed, the peak times were not substan-
tially different (PER2 = 9:07 ± 6:34, BMAL1 = 14:27 ± 4:13, 
PER3 = 5:54 ± 2:48, Cortisol = 10:28 ± 2:18), with the largest 
difference being an approximate one-hour delay in PER2 peak 
timing. There were no significant differences between either the 
amplitudes or phases of any of the circadian markers when com-
pared between PER3 VNTR genotype. However, the variance 
in the amplitude of the mean fitted z-scored melatonin rhythm 
was significantly lower in the PER35/5 subjects compared with 
the PER4/4 (1.26 ± 0.04 vs 1.23 ± 0.11; P = 0.003).
Correlation analyses were performed to assess the associa-
tion between inter-individual variation in habitual sleep timing, 
as assessed prior to the laboratory study, and the timing of the 
various marker rhythms (determined from z-scored data), as 
assessed during the CR, in those individuals with significant 
rhythm amplitudes (Table 4). Correlations are presented for 
all subjects with significant amplitude together and also when 
split according to PER3 VNTR genotype. When the data from 
all significant subjects were analyzed irrespective of genotype, 
the strongest correlation was observed between individual mid-
sleep time and the phase of melatonin (maximum) (r = 0.87, P < 
0.0001), but both melatonin onset and peak phases also showed 
significant positive correlations with sleep time, mid-sleep, and 
wake time (Table 4, Figure 4E and 4F). The timing of the fitted 
maxima of the cortisol rhythms also showed significant positive 
correlations with these sleep-wake parameters (Table 4). Of the 
3 clock genes, only the timing of the fitted maxima for PER3 
showed significant correlations with sleep-wake timing and 
with the peak of the cortisol rhythm and the onset of melatonin, 
which had the strongest correlation (r = 0.59, P = 0.005) (Table 
4, Figure 4A – 4D). No significant correlations were observed 
between PER2 or BMAL1 rhythms and sleep-wake timing or 
melatonin and cortisol (Table 4). However, unlike PER2 and 
PER3, BMAL1 showed negative correlations with the other cir-
cadian markers. None of the circadian markers correlated sig-
nificantly with the overall level of expression of the clock genes 
when expressed as relative copy number.
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0.93, P < 0.0001) (Table 4). Whereas PER34/4 homozygotes also 
showed significant correlations between sleep-wake timing and 
the timing of cortisol rhythms, there were no such significant 
correlations with cortisol within the PER35/5 subjects. However, 
it should be noted that when these correlations are compared 
between genotype they are not significantly different. Con-
versely, PER35/5 homozygotes showed significant correlations 
between PER3 expression rhythms and sleep-wake timing and 
the timing of melatonin and cortisol, with the strongest corre-
lation being with wake time (r = 0.89, P = 0.0009), whereas 
the PER34/4 homozygotes did not. In this case, the correlations 
with mid-sleep and wake time were stronger in PER35/5 indi-
viduals and were significantly different between the genotypes 
(P = 0.03 and 0.004, respectively) (Table 4). Finally, the nega-
tive correlation between sleep time and BMAL1 expression was 
only significant in the PER35/5 subjects.
diScuSSion
The present data show that the phase of clock gene expres-
sion in leukocytes, assessed in the absence of the masking 
effects of light-dark and sleep-wake cycles, correlates with 
habitual sleep timing. To date, eight published studies have 
examined the expression of clock genes in human blood 
cells.33-40 Together, these studies have characterized the ex-
pression of PER1-3, CRY1, CLOCK, BMAL1, REV-ERBα and 
DEC1 in either mononuclear cells or unseparated leukocytes 
(mononuclear and polymorphonuclear cells). Apart from one 
study that involved 61 neonates undergoing light therapy 
treatment,36 these studies have been based on smaller groups 
of 3–12 adults, providing blood samples at either 2 time points 
or every 2 to 4 h over periods ranging from 20 to 39 h. Only 
2 studies have attempted constant routine protocols,34,35 al-
though one allowed limited movement and sleep episodes.35 
Both studies reported correlations between the phases of me-
latonin and clock gene transcripts. In a recent study, the effects 
of a simulated shift work schedule on central and peripheral 
circadian markers have been studied, and blood mononuclear 
cell clock gene expression has been analysed over three 24-h 
periods during the schedule.40
The correlations between sleep-wake timing and melatonin 
rhythm timing remained, with the strongest correlation being 
between the timing of mid-sleep and the peak of melatonin 
in both genotypes (PER34/4 r = 0.83, P < 0.0001; PER35/5 r = 
Figure 4—Scatter plots showing the correlations between PER3 
expression and sleep markers for each individual (represented by 
each dot). The mean fitted z-score peak (time in hours) of PER3 
expression is plotted against (A) sleep onset (r = 0.48, P = 0.03), 
(B) wake time (r = 0.44, P = 0.055), (C) mid-sleep time (r = 0.49, P 
= 0.03), and the mean fitted z-score melatonin onset (D) (r = 0.59, 
P = 0.005) (all times in hours). Also shown are the correlations for 
melatonin onset against sleep time (E) (r = 0.78, P < 0.0001) and 
wake time (F) (r = 0.80, P < 0.0001). 
Table 3—Characterization of Circadian Rhythm Parameters
A	 	 Number	of	subjects	with	 Mean	fitted	amplitude	 Mean	fitted	maxima
	 	 Significant	amplitudes	 	 H:min	±	SD
 PER2 11/24 (46%) 388.1 ± 700.8 09:30 ± 05:39
 BMAL1 8/24 (33%) 751.6 ± 737.8 14:02 ± 04:31
 PER3 20/24 (83%) 1914.9 ± 2396.6 05:32 ± 02:47
 Cortisol 23/24 (96%) 111.6 ± 44.4 10:49 ± 01:37
 Melatonin 24/24 (100%) 31.6 ± 15.6 04:20 ± 01:18
B
 PER2 8/24 (33%) 0.01 ± 0.01 08:06 ± 05:23
 BMAL1 8/24 (33%) 0.03 ± 0.03 15:06 ± 04:28
 PER3 19/24 (79%) 0.08 ± 0.13 06:05 ± 02:14
Percentage of subjects with significant amplitudes for circadian markers and mean fitted amplitudes (± SD) and mean fitted maxima (time ± SD) 
for (A) clock gene (expressed as relative copy number), cortisol (nmol/L) and melatonin rhythms (pg/mL), and (B) clock gene rhythms expressed 
as relative copy number normalized to GAPDH. PER3 amplitude is significantly greater than BMAL1 and PER2 amplitudes when expressed as 
relative copy number (P = 0.031 and 0.006, respectively) and when normalized against GAPDH (P = 0.05 and 0.01, respectively).
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no reason to expect that PER3 should show phase differences 
in expression between peripheral mononuclear and polymor-
phonuclear cells, and the well-defined PER3 rhythm we present 
here supports this.
In this study, we found significant mRNA oscillations for 
each of the 3 clock genes, with PER3 having the highest num-
ber of participants with significant oscillations. The PER3 oscil-
lations have a mean amplitude significantly greater than that of 
PER2 and BMAL1, and a significantly smaller variance in peak 
timing. Comparison of these features shows that the robustness 
of PER3 as a circadian marker in peripheral leukocytes within 
this study is more reliable than PER2 and BMAL1.
As repeatedly reported in the published literature,10,34,40,48 we 
found highly significant correlations between sleep-wake tim-
ing and the timing of the rhythms of melatonin and cortisol. We 
also found a significant correlation between the phases of indi-
vidual PER3 and melatonin rhythms, confirming previous da-
ta.34 However, no correlations were found between the rhythms 
in melatonin and PER2, unlike the previous study by Boivin 
et al.,34 or BMAL1. In addition, the current study also shows 
significant correlations between the phase of PER3 and the tim-
ing of sleep-wake activity and the timing of cortisol rhythms, 
which were absent for PER2 and BMAL1. The negative correla-
This report is the first to investigate the association between 
habitual sleep timing and peripheral blood clock gene expres-
sion in 24 adults with sampling every hour during an approxi-
mate 40-h constant routine in the absence of a sleep-wake cycle. 
We chose to characterize the expression of 2 members of the 
negative feedback loop, PER2 and PER3, and the positive tran-
scription factor BMAL1, which normally oscillates in opposite 
phase to PER.45 We used the PAXgene RNA system for blood 
sampling. This allows for immediate stabilisation of RNA from 
leukocytes (both mononuclear and polymorphonuclear cells) 
enabling accurate results without the need for immediate sample 
extraction. The fact that we found significant circadian rhythms 
in each of the 3 clock genes that were studied demonstrates 
the reliability of this method. While it is known that peripheral 
white blood cells show a circadian variation in the number of 
their composite types,46,47 it has been shown recently that there 
is no phase difference in the expression of PER1 between hu-
man peripheral mononuclear and polymorphonuclear cells.35 
Indeed, the expression rhythms of clock genes from almost any 
peripheral tissue will be representative of a mixed cell popula-
tion. However, the existence of significant clock gene rhythms 
within peripheral tissues would suggest that most cell types are 
oscillating in close phase agreement. As with PER1, we have 
Table 4—Correlations Between Circadian Markers
Circadian Circadian r (all subjects) P (all subjects) r (PER34/4) P (PER34/4) r (PER35/5) P (PER35/5)
marker 1 marker 2
Sleep time Melatonin (onset) 0.78 < 0.0001 0.69 0.0040 0.86 0.0004
Mid-sleep Melatonin (onset) 0.84 < 0.0001 0.76 0.0007 0.92 < 0.0001
Wake time Melatonin (onset) 0.80 < 0.0001 0.72 0.0020 0.88 0.0002
Sleep time Melatonin (max) 0.80 < 0.0001 0.79 0.0006 0.87 0.0003
Mid-sleep Melatonin (max) 0.87 < 0.0001 0.83 < 0.0001 0.93 < 0.0001
Wake time Melatonin (max) 0.83 < 0.0001 0.76 < 0.0001 0.90 < 0.0001
Sleep time Cortisol (max) 0.80 0.0015 0.74 < 0.0001 0.39 (0.26)
Mid-sleep Cortisol (max) 0.67 0.0002 0.86 < 0.0001 0.48 (0.14)
Wake time Cortisol (max) 0.65 0.0040 0.85 0.0020 0.54 (0.09)
Sleep time PER3 (max) 0.48 0.030 0.06 (0.86) 0.70 0.0400
Mid-sleep PER3 (max) 0.49 0.030 -0.08 (0.80) 0.82 0.0070†
Wake time PER3 (max) 0.44 (0.055) -0.21 (0.52) 0.89 0.0009††
Melatonin (onset) PER3 (max) 0.59 0.005 0.30 (0.34) 0.80 0.0100
Cortisol (max) PER3 (max) 0.48 0.030 0.26 (0.43) 0.70 0.0400
Sleep time PER2 (max) 0.26 (0.520) -0.35 (0.67) 0.53 (0.50)
Mid-sleep PER2 (max) 0.15 (0.700) -0.65 (0.37) 0.58 (0.44)
Wake time PER2 (max) 0.03 (0.930) -0.84 (0.16) 0.63 (0.40)
Melatonin (onset) PER2 (max) 0.12 (0.770) -0.34 (0.70) 0.42 (0.60)
Cortisol (max) PER2 (max) 0.01 (0.990) -0.44 (0.58) 0.61 (0.41)
Sleep time BMAL1 (max) -0.67 (0.810) 0.36 (0.07) -0.97 0.02
Mid-sleep BMAL1 (max) -0.59 (0.100) 0.61 (0.41) -0.92 (0.08)
Wake time BMAL1 (max) -0.43 (0.610) 0.86 (0.09) -0.76 (0.25)
Melatonin (onset) BMAL1 (max) -0.61 (0.770) 0.71 (0.32) -0.77 (0.25)
Cortisol (max) BMAL1 (max) -0.30 (0.460) 0.09 (0.92) -0.46 (0.56)
Correlations between circadian markers of sleep-wake timing, clock gene expression and hormonal rhythms. Correlations with melatonin are 
for timing of either the onset or maximum of the melatonin rhythm. Correlations with cortisol and clock gene rhythms are for the timing of 
fitted maxima. Calculations of hormone and clock gene timing are taken from z-scored data, as described in the Methods and presented in the 
Results. Data have been included in the analysis only from individuals contributing significant circadian amplitudes. The data are presented 
for all subjects and split by PER3 genotype, which included for PER34/4 and PER35/5 respectively, 14 and 10 subjects for melatonin, 13 and 
10 for cortisol, 11 and 8 for PER3, 4 each for PER2, and 4 each for BMAL1. † = significant difference between PER34/4 and PER35/5 correla-
tion (P = 0.03), †† = significant difference between PER34/4 and PER35/5 correlations (P = 0.004), r = correlation coefficient, nonsignificant P 
values are given in brackets.
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sleep timing. Although there was no significant difference in di-
urnal preference between the 2 groups, it can be seen from Fig-
ure 1 that there is a range of inter-individual sleep-wake timing 
differences, with the PER35/5 subjects tending to have earlier 
habitual wake times than the PER34/4 subjects. It is also worth 
noting that within the subject group as a whole, there does ex-
ist a correlation between diurnal preference and habitual wake 
time (r = -0.42, P = 0.04), but not sleep onset. When the cor-
relations between the various circadian markers were analyzed, 
we found that both genotypes show strong correlations between 
sleep-wake timing and the timing of melatonin. However, only 
the PER34/4 individuals show significant correlations between 
sleep-wake and cortisol, and this requires further investigation. 
When the data were split by genotype, only the PER3 rhythms 
in the PER35/5 individuals showed correlations with sleep-wake 
timing and melatonin and cortisol, with the correlations with 
the timing of mid-sleep and wake being significantly different 
from the correlations in the PER34/4 individuals. In addition, 
the negative correlation between sleep time and BMAL1 was 
only ever significant in the PER35/5 subjects. This implies that 
the contribution to the significant correlations between PER3 
expression and other circadian markers observed in all 19 sub-
jects is derived mainly from the PER35/5 individuals. Therefore, 
while amplitude and phase of the circadian markers may not 
differ between the genotypes, the PER3 expression is more 
strongly associated with sleep-wake timing in PER35/5 individ-
uals. This finding is somewhat reminiscent of the notion that 
the sleep-wake cycles of morning types, with which homozy-
gosity for the longer PER3 VNTR allele is associated,23 are 
more tightly controlled by circadian rhythmicity than evening 
types.49 Thus, while we did not observe genotype-dependent 
differences in sleep-wake timing or the timing of melatonin 
and cortisol rhythms, we did find significant differences in the 
correlations of these timings between PER3 VNTR genotypes. 
However, PER3 gene expression being a marker for entrained 
phase does not necessarily imply that the VNTR polymorphism 
should lead to differences in entrained phase. It is possible that 
the polymorphism may lead to differences in diurnal preference 
through its effect on the sleep-wake homeostat, and not through 
its effect on the timing of core circadian markers. Finally, while 
previous data clearly demonstrate associations between PER3 
and sleep structure and timing in humans, animal models with 
a disruption to Per3 show only a modest effect on circadian 
phenotype, as defined by the free-running period.50 The precise 
functional contribution that PER3 makes to the sleep homeostat 
and/or the circadian clock remains to be determined.
In summary, we have performed the largest study to date 
measuring peripheral blood clock gene expression with the 
greatest temporal resolution in a constant routine in the absence 
of a masking sleep-wake cycle. We have demonstrated that in 
our study, among the clock genes measured, PER3 has the most 
robust circadian oscillation. This is not unusual since, in mice, 
PER3 shows strong circadian rhythms in brain areas such as 
the suprachiasmatic nucleus (SCN) and the organum vasculo-
sum lamina terminalis (OVLT),51 but also in many peripheral 
tissues.45 We show that the phase of PER3 expression in leu-
kocytes correlates with the phases of melatonin and cortisol, 
and with habitual sleep timing. Because the phase of leuko-
cyte PER3 transcript levels was assessed in the absence of the 
tion trend for BMAL1 is of interest and may explain why some 
studies have shown the rhythm of peripheral blood BMAL1 to 
be both out of phase (present and 37) and in phase.38 However, 
the authors of the latter study did define 2 “chronotype” subject 
groups in which the phases of PER2 and BMAL1 were 01:44 
and 21:45, and 10:33 and 12:30, respectively. In this study, the 
average peak times of expression for PER3, PER2 and BMAL1 
were 06:05, 08:06, and 15:06, respectively. Similar expression 
peaks have been reported for PER2 and PER3, which are very 
similar to the peak time presented here for PER3, although 
the previous report found an approximately 6-h range across 
3 subjects for both genes.34 More recently, it has been reported 
that after adaptation to a shift schedule, PER2 peak expression 
occurred shortly after the scheduled wake period and that the 
BMAL1 peak (during baseline) was out of phase with respect to 
PER2, occurring 14.6 h after wake.40 PER1, 2 and 3 were also 
found to have similar phase peaks around 06:00 in the study by 
Takimoto et al., who also presented data showing more robust 
rhythms in PER3.37 Another study, using the same PAXgene 
purification method for leukocyte RNA, reported a peak time 
of 07:34 for PER1, but they did not detect significant rhythms 
in either PER2 or BMAL1.39 Finally, when we compared these 
correlations for significant differences, we found that the corre-
lation between melatonin onset and sleep time is stronger than 
PER3 peak timing (P = 0.006), but that a similar comparison 
showed that the correlation between cortisol peak timing and 
sleep time is no better than for PER3 (P = 0.18).
Taken together, the findings from these studies indicate that 
there are significant inter-individual differences in the timing of 
peripheral blood clock gene rhythms, especially with respect to 
BMAL1, and that out of all of the genes so far analyzed, PER3 
demonstrates the greatest consistency. However, the data from 
previous studies may suffer from less frequent sampling and 
fewer numbers of subjects studied. It is possible that, all things 
being equal, other clock genes apart from the ones analysed 
here could also show equally robust rhythms. In addition, there 
will be differences in the expression of circadian markers be-
tween central and peripheral oscillators, and also between dif-
ferent peripheral oscillators. It is possible that the robustness of 
PER3 that is found in this and other studies is a specific feature 
of the peripheral leukocyte oscillator. Nevertheless, in this data 
set, and in other currently available data sets, PER3 rhythmicity 
compares favourably to rhythmicity in other clock genes.
Previously, we have reported that the PER3 VNTR polymor-
phism is associated with diurnal preference and delayed sleep 
phase disorder.23 In a separate laboratory study, we have also 
shown that the polymorphism is predictive of sleep structure and 
cognitive performance.27 The subjects providing blood samples 
for the current investigation were from the same study protocol. 
Consequently, all of the variables that have been reported here 
can be split and analyzed by PER3 VNTR genotype. When this 
was performed on data averaged for each group, no differences 
were found in the amplitudes or phases of any of the circadian 
markers between the PER34/4 or PER35/5 individuals. However, 
the melatonin amplitude variance was significantly lower in the 
PER35/5 subjects and this could reflect more robust melatonin 
rhythms in these individuals.
For this study, subjects were selected by PER3 VNTR geno-
type alone and not on the basis of diurnal preference or habitual 
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mechanisms by which PER3 mRNA levels in the periphery are 
synchronized to the central circadian pacemaker, habitual sleep 
timing and melatonin timing remains to be established.
Taken together, these data show that the rhythm of PER3 
expression in leukocytes represents a reliable molecular marker 
for the assessment of entrained phase in healthy individuals. 
There are PER3 VNTR genotype-dependent effects on the as-
sociation between the phase of PER3 expression and sleep-
wake timing, as well as other circadian markers. Assessment of 
the PER3 rhythm in advanced and delayed sleep phase disorder 
may provide further insights into the mechanism underlying 
these circadian sleep timing disorders.
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Supplementary Figure S1—Individual clock gene oscillations. 
Relative copy number/GAPDH ratio data for PER3, PER2, and 
BMAL1 for each individual plotted against time in hours. The data 
have been fitted as described in the methods section.
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